Pharmosa Biopharm Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	631.23	749.44	974.06	672.51	461.46
Short-Term Investments	500	869	-	-	-
Cash & Short-Term Investments	1,131	1,618	974.06	672.51	461.46
Cash Growth	-30.10%	66.16%	44.84%	45.73%	11.32%
Accounts Receivable	2.01	4.65	-	-	-
Other Receivables	6.91	6.69	1.47	0.29	0.31
Receivables	8.92	11.34	1.47	0.29	0.31
Inventory	19.81	24.74	21.91	-	-
Prepaid Expenses	42.93	27.22	12.67	11.65	14.18
Other Current Assets	1.46	-	-	-	0.02
Total Current Assets	1,204	1,682	1,010	684.45	475.96
Property, Plant & Equipment	458.67	315.06	180.61	30.12	33.44
Long-Term Investments	72.37	73.26	71.22	65.69	61.6
Other Intangible Assets	0.99	0.66	0.09	0.15	0.18
Other Long-Term Assets	12.15	92.88	71.62	18.95	15.19
Total Assets	1,749	2,164	1,334	799.37	586.37
Accounts Payable	8.13	0.68	0.59	-	-
Accrued Expenses	-	61.51	33.24	12.28	11.66
Current Portion of Long-Term Debt	-	-	1.26	3.52	8.43
Current Portion of Leases	18.6	17.98	24.69	7.19	6.8
Current Unearned Revenue	-	6.89	-	-	-
Other Current Liabilities	72.73	29.07	17.8	4.77	6.19
Total Current Liabilities	99.47	116.13	77.58	27.77	33.07
Long-Term Debt	-	-	1.19	2.45	5.96
Long-Term Leases	81.01	99.62	117.23	8.04	15.9
Long-Term Unearned Revenue	4.82	4.82	-	-	-
Other Long-Term Liabilities	5.27	5.1	-	-	-
Total Liabilities	190.57	225.66	195.99	38.25	54.93
Common Stock	645.76	645.43	586.02	554.67	489.24
Additional Paid-In Capital	1,283	1,439	531.34	1,180	-
Retained Earnings	-371.18	-146.37	20.28	-973.44	-706.94
Comprehensive Income & Other	0.01	0.02	0.01	0.01	749.13
Shareholders' Equity	1,558	1,938	1,138	761.12	531.44
Total Liabilities & Equity	1,749	2,164	1,334	799.37	586.37
Total Debt	99.61	117.6	144.37	21.19	37.09
Net Cash (Debt)	1,032	1,501	829.69	651.32	424.37
Net Cash Growth	-31.26%	80.89%	27.39%	53.48%	46.28%
Net Cash Per Share	7.98	11.87	7.32	6.61	5.00
Filing Date Shares Outstanding	129.71	129.09	117.2	110.93	97.85
Total Common Shares Outstanding	129.71	129.09	117.2	110.93	97.85
Working Capital	1,105	1,566	932.53	656.68	442.89
Book Value Per Share	12.01	15.01	9.71	6.86	5.43
Tangible Book Value	1,557	1,937	1,138	760.97	531.25
Tangible Book Value Per Share	12.00	15.01	9.71	6.86	5.43
Machinery	-	68.34	27.11	26.37	17.05
Construction In Progress	-	134.42	-	-	-
Leasehold Improvements	-	28.85	35.61	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.